 |
|
 |
K2K2 - NOW MINT-FLAVORED!!!
April 2002
Home
Page
Related
Links
Classified
Ads
What's
Hot!!!
Regular
Issues
Special
Issues
Beast
Of The Month
Robalini
The
Vault
Klearinghouse
Nevirapine does work! But how?
LIFE EXPANSION UNIVERSITY
Dear Fellow Human,
Nevirapine, also called Viramune, is the drug the AIDS-DRUGS lobby wants to force the South African government to give to pregnant women in order "to reduce transmission of HIV from mother to child", even though the drug has not been approved in the USA for this purpose, and has never been proven safe, let alone for use during pregnancy.
Please read below what the manufacturer itself (!) writes about this drug, and then tell me if you - assuming you are an expectant mother - would accept to take it, even if it is given to you free of charge? And even if there were such a thing as transmission of the "AIDS virus" from mother to child during pregnancy or childbirth, which for now is nothing but a speculative hypothesis of very bad science.
The basis for prescription of this life-threatening drug to pregnant women is a non-specific antibody test that does not prove infection with HIV or any other virus, neither in the mother, nor in the child.
This is all pure conjecture based on indirect and non-specific markers, that can be triggered in the blood by more than 60 different medical conditions, many of them very common, including pregnancy (!!!), vaccinations (!!), influenza (!), hepatitis, tuberculosis, malaria, parasites, etc., etc.
And, as if this weren´t enough, there is absolutely no scientific proof that HIV causes AIDS, even if this elusive retrovirus really could be proved to be present.
All who REALLY want to know the truth can verify all this for themselves, although in doing so, they cannot expect much help from AIDS Inc.
I strongly recommend you to look up the website www.aliveandwell.org which will open your eyes to what is going on with regard to AIDS and HIV.
Amazingly, the Druggist lobby has even succeeded in getting a South African high court to rule that the Government must provide this drug to all pregnant women who "test positive to HIV". As if a court of law were more medically competent to prescribe force-feeding a specific life-threatening drug to expectant mothers than the country´s proper health authorities!
I have got this information from a letter by the US researcher Dr. David Rasnick who for decades has specialized in precisely the kind of drugs prescribed for AIDS, and who is one of the leading scientists on President Mbeki´s AIDS research panel. The letter was written in response to a news headline reading "Nevirapine Does Work, US Researchers Tell South Africa".
"Nevirapine does indeed work. Here's what it does according to it's manufacturer:
'Boehringer Ingelheim Pharmaceuticals, Inc. 2001,
Viramune ® (nevirapine)
WARNING
Severe, life-threatening, and in some cases fatal hepatotoxicity, including fulminant and cholestatic hepatitis, hepatic necrosis and hepatic failure, has been reported in patients treated with VIRAMUNE ????. In some cases, patients presented with non-specific prodromal signs or symptoms of hepatitis and progressed to hepatic failure. Some events occurred after short-term exposure to VIRAMUNE. Patients with signs or symptoms of hepatitis must seek medical evaluation immediately and should be advised to discontinue VIRAMUNE. (See WARNINGS)
Severe, life-threatening skin reactions, including fatal cases, have occurred in patients treated with VIRAMUNE. These have included cases of Stevens-Johnson syndrome, toxic epidermal necrolysis, and hypersensitivity reactions characterized by rash, constitutional findings, and organ dysfunction. Patients developing signs or symptoms of severe skin reactions or hypersensitivity reactions must discontinue VIRAMUNE as soon as possible. (See WARNINGS)
The first 12 weeks of therapy with VIRAMUNE are a critical period during which it is essential that patients be monitored intensively to detect potentially life-threatening hepatotoxicity or skin reactions. VIRAMUNE should not be restarted following severe hepatic, skin or hypersensitivity reactions. In addition, the 14-day lead-in period with VIRAMUNE 200 mg daily dosing must be strictly followed. (See WARNINGS)' "
Sounds reassuring, doesn´t it?
Please spread this information as widely as you can!
Yours,
